Starting today, a new rule requires drug commercials to clearly show the potential side effects and when not to take the medicine. This update to a 2007 law gives the FDA more control over drug advertising. Drugmakers have six months to comply with the new rule fully, and it’s unclear how aggressively the FDA will enforce the requirements, per Ropes & Gray. It’s a good step, but a lot more is needed.

The spread of misinformation and disinformation, especially regarding health topics, has become a significant public health concern. Social media allows unverified – and often downright dangerous – health claims to spread at an unprecedented rate. The Food and Drug Administration (FDA) is actively working to address this problem and protect consumers from this kind of misleading content.

Drug approval by regulatory agencies, notably the U.S. Food and Drug Administration (FDA), is a crucial step in ensuring the safety and efficacy of pharmaceuticals before they reach the market. However, in recent years, there has been growing debate over whether the FDA’s approval process has become excessively stringent, potentially hindering innovation and delaying patient access to life-saving treatments. In this blog post, we’ll delve into the complexities of the FDA’s drug approval process, explore common misconceptions, and examine whether the agency is becoming too demanding in approving new drugs.

Prescription drug advertising has increased year after year, but are THE ads really effective? The FDA is requiring a statutory requirement that in human prescription drug advertisements presented directly to consumers in television or radio format and stating the name of the drug and its conditions of use (DTC TV/radio ads), the major statement relating to side effects and contraindications must be presented in a clear, conspicuous, and neutral manner.

In a world where the desire for quick fixes and instant results is all too common, it’s no surprise that the weight loss industry is constantly evolving. The promise of a slimmer, healthier body with minimal effort is undoubtedly tempting, leading many to explore new weight loss drugs as a potential solution. However, the dangers associated with these drugs are often underestimated or overlooked. Popular semaglutide injectable  Ozempic will now have a warning about intestinal blockage after the Food and Drug Administration accepted manufacturer Novo Nordisk’s proposed changes to the drug’s packaging.